Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

Buzz on the Bullboards: Three engaging TSX stocks with a holiday flavour

TSX this week The TSX has experienced a rocky week, marked by five consecutive sessions of declines. This downturn coincided with the unexpected resignation of Canada’s Finance Minister , Chrystia Freeland, just hours before she was scheduled to pre...

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Are you anticipating a calm market as the holidays approach? Think again. Astute investors and brokers recognize that this is their moment to excel. With the global economy constantly shifting, staying active is the smart move. Over the past week, some shareholde...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Rick Rule's holiday gifts to grow wealth

The average Canadian will spend C$1478 this holiday season with 43 per cent of the budget spent with online platforms Rule likes the idea of gifting precious metals and company shares as an alternative to traditional Christmas gifts “Philanthropy with a...

How this company is transforming the immersive tech industry

The immersive technology market size continues generating traction with the market projected to reach US$159.94 billion in 2024, according to market research . In the coming years, it will continue increasing at a rapid rate to reach US$638.69 billion in 2028, represent...

The company revolutionizing access to care and natural remedies

The Market Online recently spoke with Liz Viccars, CEO of AJA Health and Wellness Inc. (TSXV:AJA) a company transforming healthcare with its total health access service offering telemedicine, diagnostics and specialized care via proprietary tech. Additionally, AJA Heal...

Visionstate set to leverage success in the U.S. market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Visionstate Corp (TSXV:VIS) , a company whose vision is to be the leading global provider of IoT solutions for facility management. Their flagship software WANDA i...

Buzz on the Bullboards: TSX stocks to watch after Trump’s win

The past week the TSX and Wall Street saw a significant surge following Donald Trump’s return to the presidency. This political shift is expected to have profound implications for various sectors, particularly the financial and energy industries. Inv...

Prospera Energy corporate update: 3 years of strategic restructuring, recovery and future growth

CALGARY, Alberta, Oct. 24, 2024 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“PEI”) (TSX.V: PEI, OTC: GXRFF, FRA: OF6B) The 2024 Prospera corporate update outlines the company’s restructuring efforts since 2021, highlighting key m...
1 2 3 4 5 6 7 8 9 10 ...